This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007;39(4):188-90.

doi: 10.1159/000103578. Epub 2007 Jun 6.

Inhibiting angiogenesis in retinoblastoma

Rajendra S Apte, J William Harbour

PMID: 17556838
DOI: 10.1159/000103578

Review

Inhibiting angiogenesis in retinoblastoma

Rajendra S Apte et al. Ophthalmic Res. 2007.

. 2007;39(4):188-90.

doi: 10.1159/000103578. Epub 2007 Jun 6.

Authors

Rajendra S Apte, J William Harbour

PMID: 17556838
DOI: 10.1159/000103578

No abstract available

PubMed Disclaimer

Similar articles

Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
Querques G. Querques G. Am J Ophthalmol. 2009 Feb;147(2):375-6; author reply 376-7. doi: 10.1016/j.ajo.2008.10.008. Am J Ophthalmol. 2009. PMID: 19166716 No abstract available.
Photodynamic therapy in the anti-VEGF era.
Fine HF. Fine HF. Br J Ophthalmol. 2007 Jun;91(6):707-8. doi: 10.1136/bjo.2007.114041. Br J Ophthalmol. 2007. PMID: 17510474 Free PMC article.
Strategies for inhibiting vascular endothelial growth factor.
Kaiser PK. Kaiser PK. Retina. 2009 Jun;29(6 Suppl):S15-7. doi: 10.1097/IAE.0b013e3181ad240c. Retina. 2009. PMID: 19553789
How to overcome retinal neuropathy: the fight against angiogenesis-related blindness.
Jo DH, Kim JH, Kim JH. Jo DH, et al. Arch Pharm Res. 2010 Oct;33(10):1557-65. doi: 10.1007/s12272-010-1007-6. Epub 2010 Oct 30. Arch Pharm Res. 2010. PMID: 21052933 Review.
[Experience with vascular endothelial growth factor inhibitors used in ophthalmologic care].
Khalaim AV, Stoliarenko GE. Khalaim AV, et al. Vestn Oftalmol. 2007 Sep-Oct;123(5):54-6, preceding 56. Vestn Oftalmol. 2007. PMID: 18078062 Review. Russian. No abstract available.

See all similar articles

Cited by

Netrin-1 promotes retinoblastoma-associated angiogenesis.
Yang X, Sun H, Tang T, Zhang W, Li Y. Yang X, et al. Ann Transl Med. 2021 Nov;9(22):1683. doi: 10.21037/atm-21-5560. Ann Transl Med. 2021. PMID: 34988192 Free PMC article.
Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis.
Theodoropoulou S, Brodowska K, Kayama M, Morizane Y, Miller JW, Gragoudas ES, Vavvas DG. Theodoropoulou S, et al. PLoS One. 2013;8(1):e52852. doi: 10.1371/journal.pone.0052852. Epub 2013 Jan 3. PLoS One. 2013. PMID: 23300996 Free PMC article.
Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.
Kim M, Kim JH, Kim JH, Kim DH, Yu YS. Kim M, et al. Korean J Ophthalmol. 2010 Feb;24(1):35-9. doi: 10.3341/kjo.2010.24.1.35. Epub 2010 Feb 5. Korean J Ophthalmol. 2010. PMID: 20157412 Free PMC article.
mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models.
Tang L, Fu Y, Song J, Hu T, Li K, Li Z. Tang L, et al. Pharmacol Res Perspect. 2022 Feb;10(1):e00930. doi: 10.1002/prp2.930. Pharmacol Res Perspect. 2022. PMID: 35142090 Free PMC article.
PEDF inhibits growth of retinoblastoma by anti-angiogenic activity.
Yang H, Cheng R, Liu G, Zhong Q, Li C, Cai W, Yang Z, Ma J, Yang X, Gao G. Yang H, et al. Cancer Sci. 2009 Dec;100(12):2419-25. doi: 10.1111/j.1349-7006.2009.01332.x. Epub 2009 Aug 27. Cancer Sci. 2009. PMID: 19832843 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland